2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide
2022.1.0 - CI Build

2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide, published by Centers for Disease Control and Prevention (CDC). This guide is not an authorized publication; it is the continuous build for version 2022.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/opioid-cds-r4/ and changes regularly. See the Directory of published versions

ValueSet: Methadone urine drug screening tests

Official URL: http://fhir.org/guides/cdc/opioid-cds/ValueSet/methadone-urine-drug-screening-tests Version: 2022.1.0
Active as of 2023-05-25 Computable Name: METHADONE_URINE_DRUG_SCREENING_TESTS

Copyright/Legal: © CDC 2016+.

Urine tests to identify methadone and metabolites

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

  • Include codes fromhttp://loinc.org version Not Stated (use latest from terminology server) where parent = LP15015-8 (Methadone), SYSTEM = LP7681-2 (Urine) and CLASSTYPE = 1

 

Expansion

This value set contains 25 concepts

SystemVersionCodeDisplayJSONXML
http://loinc.org2.74  78770-5Methadone [Mass/volume] in Urine -- adjusted for lean body mass+urine creatinine
http://loinc.org2.74  41466-4Methadone/Creatinine [Mass Ratio] in Urine
http://loinc.org2.74  19552-9Methadone cutoff [Mass/volume] in Urine for Screen method
http://loinc.org2.74  19553-7Methadone cutoff [Mass/volume] in Urine for Confirmatory method
http://loinc.org2.74  78857-0Methadone [Z-score] in Urine
http://loinc.org2.74  52958-6Methadone [Moles/volume] in Urine
http://loinc.org2.74  70149-0Methadone [Presence] in Urine by Screen method >300 ng/mL
http://loinc.org2.74  70148-2Methadone [Presence] in Urine by Screen method >150 ng/mL
http://loinc.org2.74  19550-3Methadone [Presence] in Urine by Screen method
http://loinc.org2.74  16199-2Methadone [Presence] in Urine by Confirmatory method
http://loinc.org2.74  3773-9Methadone [Presence] in Urine
http://loinc.org2.74  70147-4Methadone [Mass/volume] in Urine by Screen method
http://loinc.org2.74  16246-1Methadone [Mass/volume] in Urine by Confirmatory method
http://loinc.org2.74  3774-7Methadone [Mass/volume] in Urine
http://loinc.org2.74  3775-4Methadone [Mass/time] in 24 hour Urine
http://loinc.org2.74  58390-62-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP)/Creatinine [Mass Ratio] in Urine
http://loinc.org2.74  77752-42-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Urine for Screen method
http://loinc.org2.74  77754-02-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) cutoff [Mass/volume] in Urine for Confirmatory method
http://loinc.org2.74  93495-02-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Screen method
http://loinc.org2.74  58428-42-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Confirmatory method
http://loinc.org2.74  41858-22-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine
http://loinc.org2.74  58429-22-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine by Confirmatory method
http://loinc.org2.74  50542-02-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Mass/volume] in Urine
http://loinc.org2.74  42251-9Methadone+Metabolite [Presence] in Urine by Screen method
http://loinc.org2.74  33527-3Methadone.long acting metabolite [Mass/volume] in Urine

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code